A comparative evaluation of fixed dose and separately administered combinations of lisinopril and hydrochlorothiazide in treatment-naïve adult hypertensive patients in a rural Nigerian community
Background: Antihypertensive drugs administered as fixed dose combination (FDC) therapy compared to separately administered combination therapy have been proposed to improve treatment compliance/adherence, and therefore the efficacy of blood pressure (BP) control treatment. Aim: The aim of this pres...
Main Authors: | Ugochinyere Ogudu, Obiyo Nwaiwu, Olumuyiwa John Fasipe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | International Journal of Cardiology. Cardiovascular Risk and Prevention |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772487522000204 |
Similar Items
-
The results of the international clinical study VICTORY:efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide(Valsacor® H)in routine clinical practice in patients with hypertens
by: Chazova I.E., et al.
Published: (2017-05-01) -
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
by: I E Chazova, et al.
Published: (2017-06-01) -
FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS
by: A. O. Shevchenko, et al.
Published: (2016-01-01) -
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
by: E Evgen'evna Chazova, et al.
Published: (2015-06-01) -
ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE
by: E. A. Ryabikhin, et al.
Published: (2016-01-01)